Ovarian Dysgerminoma / Disgerminom Jajnika

1. Yoon S, Park HG, Kuk JY, Oak SA, Park JH. A case of ovarian dysgerminoma with gonadal dysgenesis in 29-year-old woman with 46,XX karyotype. Korean J Obstet Gynecol. 2012;55(10):772-6.10.5468/KJOG.2012.55.10.772Search in Google Scholar

2. Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075-85.10.1097/01.AOG.0000216004.22588.ce16648414Search in Google Scholar

3. Tangjitgamsol S, Hanprasertpong J, Manusirvithaya S, Wootipoom V, Thavaramara T, Buhachat R. Malignant ovarian germ cell tumors: clinic-pathological presentation and survival outcomes. ActaObstetGynecol Scand. 2010;89(2):182-9.10.3109/0001634090344368419961281Search in Google Scholar

4. Vicus D, Beiner M, Klachook S, Le L, Laframboise S, Mackay H. Purge dysgerminoma of the ovary 35 years on: A single institutional experiences. GynecolOncol. 2010:117(1):23-6.10.1016/j.ygyno.2009.12.02420097412Search in Google Scholar

5. Biswajit D, Patil CN, Sagar TG. Clinical presentation and outcome of pediatric ovarian germ cell tumor: A study of 40 petients. J Pediatric Hematol Oncol.2010;32(2):e54-e56.10.1097/MPH.0b013e3181c5ad9b20168245Search in Google Scholar

6. Boran N, Tulunay G, Callskan E, Kose MF, Haberal A. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminoma. Arch Gynecol Obstet. 2005;271:104-8.10.1007/s00404-004-0601-615007601Search in Google Scholar

7. Akhtar K, Shamshad Ahmad S, Kumar A, Afshan N. Dysgerminoma with pregnancy and viable baby: a case report. Oman Med J. 2011;26(3):198-200.10.5001/omj.2011.48319170022043416Search in Google Scholar

8. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali- Fehmi R, et al. “The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary,” GynecolOncol. 2008; 110(2): 125-32.Search in Google Scholar

9. Radhakrishhnan S, Haq S, Lofts F, Young MPA, Barton DRJ. Ovarian dysgerminoma presenting with hypercalcaemia. BJOG. 2001;108(12):1302-4.Search in Google Scholar

10. Lee IH, Choi CH, Hong DG, Song JY, Kim YJ, Kim KT.et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J GynecolOncol. 2011;22:188-95.10.3802/jgo.2011.22.3.188318871821998762Search in Google Scholar

11. Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevrean C, Kerbrat P, et al. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2008;18:446-52.10.1111/j.1525-1438.2007.01049.x18494093Search in Google Scholar

12. Talukadar S, Kumar S, Bhatla N, Mathur S, Thulkar S, Kumar L. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol.2014;132:28.10.1016/j.ygyno.2013.10.00924145115Search in Google Scholar

13. Zanetta G, Bonazzi C, Cantu M, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J ClinOncol. 2001;19(4):1015-20.10.1200/JCO.2001.19.4.101511181664Search in Google Scholar

14. Colombo N, Peiretti M, Garbi A, Garinelli S, Marini C, Sessa C. Non-epithelial ovarian cancer: ESMO clinical practice guidelines. Ann Oncol. 2012;23(7):20-6. 10.1093/annonc/mds22322997450Search in Google Scholar